|
1
|
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
|
N Engl J Med
|
1996
|
5.56
|
|
2
|
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
|
J Clin Oncol
|
1999
|
5.53
|
|
3
|
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
|
J Clin Oncol
|
1992
|
1.26
|
|
4
|
4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.
|
Proc Natl Acad Sci U S A
|
1995
|
1.15
|
|
5
|
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.
|
Cancer
|
1993
|
1.14
|
|
6
|
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer.
|
J Cancer Res Clin Oncol
|
1997
|
1.12
|
|
7
|
Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer.
|
Cancer Invest
|
1998
|
1.07
|
|
8
|
Uterine leiomyosarcoma.
|
Am J Obstet Gynecol
|
1979
|
0.90
|
|
9
|
Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix.
|
Obstet Gynecol
|
1996
|
0.90
|
|
10
|
Epithelial ovarian neoplasms of low malignant potential.
|
Gynecol Oncol
|
1985
|
0.88
|
|
11
|
Tumor board in gynecologic oncology.
|
Int J Gynecol Cancer
|
2004
|
0.87
|
|
12
|
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
|
J Clin Oncol
|
1987
|
0.86
|
|
13
|
Cone biopsy during pregnancy.
|
Obstet Gynecol
|
1982
|
0.85
|
|
14
|
Long-term survival with metastatic uterine sarcoma.
|
N Y State J Med
|
1985
|
0.84
|
|
15
|
A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers.
|
Int J Gynecol Cancer
|
2006
|
0.84
|
|
16
|
Adjuvant chemotherapy in early uterine sarcoma.
|
Gynecol Oncol
|
1983
|
0.84
|
|
17
|
Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis.
|
Cancer J Sci Am
|
2006
|
0.83
|
|
18
|
Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix.
|
Obstet Gynecol
|
1993
|
0.82
|
|
19
|
Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Can it replace cold knife conization?
|
J Reprod Med
|
1996
|
0.82
|
|
20
|
Evaluation of amonafide in cervical cancer, phase II. A SWOG study.
|
Am J Clin Oncol
|
1992
|
0.82
|
|
21
|
Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
|
Am J Clin Oncol
|
1990
|
0.81
|
|
22
|
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group.
|
Gynecol Oncol
|
1996
|
0.81
|
|
23
|
Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer.
|
J Clin Endocrinol Metab
|
1988
|
0.81
|
|
24
|
Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
|
J Reprod Med
|
1999
|
0.80
|
|
25
|
Treatment of advanced uterine sarcoma with adriamycin.
|
Gynecol Oncol
|
1983
|
0.79
|
|
26
|
Mixed müllerian tumors of the uterus: a clinicopathologic study.
|
Obstet Gynecol
|
1989
|
0.79
|
|
27
|
Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide.
|
Gynecol Oncol
|
1983
|
0.79
|
|
28
|
Management of patients with positive margins after cervical conization.
|
Obstet Gynecol
|
1993
|
0.79
|
|
29
|
Cervical cancer, a major killer of Hispanic women: implications for health education.
|
Health Educ
|
1989
|
0.79
|
|
30
|
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).
|
Gynecol Oncol
|
2001
|
0.79
|
|
31
|
Carcinoma in situ of the vulva. A clinicopathologic study of 50 cases.
|
J Reprod Med
|
1986
|
0.78
|
|
32
|
Bone metastasis in epithelial ovarian carcinoma.
|
Int J Gynaecol Obstet
|
1996
|
0.78
|
|
33
|
A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
|
Gynecol Oncol
|
1990
|
0.78
|
|
34
|
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
|
Gynecol Oncol
|
1999
|
0.78
|
|
35
|
Human papillomavirus testing for triage in a referral population.
|
J Low Genit Tract Dis
|
2001
|
0.77
|
|
36
|
Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers.
|
In Vitro Cell Dev Biol Anim
|
1997
|
0.77
|
|
37
|
XY gonadal dysgenesis with gonadoblastoma and dysgerminoma.
|
South Med J
|
1984
|
0.77
|
|
38
|
The cytologist and bacterioses of the vaginal-ectocervical area. Clues, commas and confusion.
|
Acta Cytol
|
1989
|
0.77
|
|
39
|
MR imaging of uterine cervical carcinoma.
|
J Comput Assist Tomogr
|
1988
|
0.75
|
|
40
|
Treatment of human papillomavirus-associated vulvar disease with the CO2-laser. Physical and histological aspects with use of a new scanning device, the SwiftLase.
|
Arch Gynecol Obstet
|
1996
|
0.75
|
|
41
|
Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
|
Obstet Gynecol
|
1988
|
0.75
|
|
42
|
Template specificities of a RNA-directed DNA polymerase from a human homologous mixed mesodermal sarcoma.
|
Oncology
|
1983
|
0.75
|
|
43
|
Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.
|
Gynecol Oncol
|
1987
|
0.75
|
|
44
|
Dermatofibrosarcoma protuberans of the vulva: report of two new cases and review of the literature.
|
J Low Genit Tract Dis
|
1999
|
0.75
|
|
45
|
Surgical blood loss in abdominal hysterectomy.
|
Gynecol Oncol
|
2001
|
0.75
|
|
46
|
Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
|
Cancer Treat Rep
|
1984
|
0.75
|
|
47
|
Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix.
|
Gynecol Oncol
|
1984
|
0.75
|
|
48
|
Hyperthecosis of the ovaries in a woman with a placental site trophoblastic tumor.
|
Obstet Gynecol
|
1990
|
0.75
|
|
49
|
Necessity of endocervical curettage in colposcopy.
|
Am J Obstet Gynecol
|
1986
|
0.75
|
|
50
|
Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
|
J Clin Endocrinol Metab
|
1986
|
0.75
|
|
51
|
Conservative management of positive resection margins after loop electrosurgical excision procedure.
|
J Low Genit Tract Dis
|
1998
|
0.75
|
|
52
|
Chronic plasma cell cervicitis simulating a cervical malignancy: a case report.
|
Obstet Gynecol
|
1993
|
0.75
|
|
53
|
Simultaneously occurring condylomata acuminata, carcinoma in situ and verrucous carcinoma of the vulva and carcinoma in situ of the cervix in a young woman. A case report.
|
J Reprod Med
|
1988
|
0.75
|
|
54
|
Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy.
|
Gynecol Oncol
|
2001
|
0.75
|
|
55
|
Avoiding conization for inadequate colposcopy. Suggestions for conservative therapy.
|
J Reprod Med
|
1996
|
0.75
|
|
56
|
Papanicolaou smears of atypical glandular cells of undetermined significance: histological correlations and suggestions for management.
|
J Low Genit Tract Dis
|
1999
|
0.75
|
|
57
|
Reexploration after treatment for uterine sarcoma.
|
Gynecol Oncol
|
1983
|
0.75
|
|
58
|
Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
|
J Reprod Med
|
1997
|
0.75
|
|
59
|
Necessity for endocervical curettage in elderly women undergoing colposcopy.
|
J Reprod Med
|
1989
|
0.75
|
|
60
|
Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.
|
Gynecol Oncol
|
1987
|
0.75
|
|
61
|
m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study.
|
Invest New Drugs
|
1984
|
0.75
|
|
62
|
Lower genital tract metastases of placental site trophoblastic tumor: case report and review of the literature.
|
J Low Genit Tract Dis
|
2000
|
0.75
|
|
63
|
MRI of cervical carcinoma.
|
Semin Ultrasound CT MR
|
1988
|
0.75
|
|
64
|
Frozen section evaluation of cervical conization specimens.
|
J Reprod Med
|
1986
|
0.75
|
|
65
|
Management of cervical intraepithelial neoplasia during pregnancy: a simplified and cost-effective approach.
|
J Low Genit Tract Dis
|
1998
|
0.75
|
|
66
|
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial.
|
Gynecol Oncol
|
1990
|
0.75
|
|
67
|
Correlation of the Digene HPV Assay Hybrid Capture System with Colposcopically Guided Biopsy Results.
|
J Low Genit Tract Dis
|
1999
|
0.75
|